1491 — Chugai Mining Co Share News
0.000.00%
Last trade - 00:00Brief: Chugai and Galderma announce global license agreement for Nemolizumab
Brief: Chugai Pharmaceutical announces results of Japanese phase III study of Alecensa
Table: Chugai Mining -2015/16 parent results
Table: Chugai Mining -2015/16 group forecast
Table: Chugai Mining -2015/16 group results
Table: Chugai Mining -9-MTH group results
Table: Chugai Mining -6-MTH group results
2015 6-month group forecast